Related Experiment Videos
Antimicrobial therapy in dialysis patients. I. Penicillins and cephalosporins
Abstract:
Antibiotic therapy, using penicillins or cephalosporins, is frequently required in patients on maintenance hemodialysis. Points to consider are dose adjustment for drugs which are excreted via the kidney, drug dialysability, and cumulation with frequent occurrence of side reactions, neurotoxicity and bleeding being the clinically most important ones. For third-generation cephalosporins with N-methylthiotetrazole side chain, impaired intrahepatic vitamin K metabolism may cause problems of hemostasis which can be avoided by dose adjustment and prophylactic administration of vitamin K1.
Insights
Antibiotic therapy in hemodialysis patients requires careful dose adjustment due to kidney excretion. Specific cephalosporins may affect vitamin K, necessitating prophylactic vitamin K1 to prevent bleeding complications.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Antibiotic use, particularly penicillins and cephalosporins, is common in patients undergoing maintenance hemodialysis.
- Drug dosing and potential adverse effects require special consideration in this population due to altered drug clearance and increased risk of complications.
Purpose of the Study:
- To review the key considerations for antibiotic therapy in patients on maintenance hemodialysis.
- To highlight potential complications such as neurotoxicity and bleeding, and discuss management strategies.
Main Methods:
- Review of existing literature on antibiotic pharmacokinetics and pharmacodynamics in hemodialysis patients.
- Analysis of clinical data regarding adverse events associated with antibiotic use in this cohort.
Main Results:
- Dose adjustments are crucial for renally excreted antibiotics in hemodialysis patients.
- Drug dialysability and potential for drug accumulation must be assessed to prevent toxicity.
- Third-generation cephalosporins with N-methylthiotetrazole side chains can impair vitamin K metabolism, leading to hemostatic problems.
Conclusions:
- Careful antibiotic selection and dose management are essential for hemodialysis patients.
- Prophylactic vitamin K1 administration can mitigate bleeding risks associated with specific cephalosporins.
- Monitoring for and managing side reactions like neurotoxicity and bleeding is critical for patient safety.